Purpose Liver transplant (LT) is the only definitive treatment for end-stage liver disease
(ESLD). This review aims to explore current global LT practices, with an emphasis on …

Background & Aims Adult-to-adult living donor liver transplantation (LDLT) offers an
opportunity to decrease the liver transplant waitlist and reduce waitlist mortality. We sought …

Abstract In the United States, living donor liver transplantation (LDLT) is limited to transplant
centers with specific experience. However, the impact of recipient characteristics on …

Background: Liver transplantation is one of the most effective treatments for acute liver
failure, chronic liver cirrhosis, and hepatocellular carcinoma. This study was implemented to …

Primary sclerosing cholangitis (PSC) is the leading indication of liver transplantation (LT)
among autoimmune liver disease patients. There is a scarcity of studies comparing survival …

Importance It is unclear whether center-level factors are associated with racial equity in
living donor kidney transplant (LDKT). Objective To evaluate center-level factors and racial …

Background Biliary atresia (BA) remains the number one indication for paediatric liver
transplantation (LT) worldwide but is an uncommon indication for older LT recipients. The …

The liver transplantation (LT) landscape is continuously evolving. We sought to evaluate
trends in indications for LT in Canada and the impact of primary liver disease on post‐LT …

Living liver donation (LLD) has been suggested as a potential solution to reduce the waitlist
mortality for liver transplantation (LT) recipients by facilitating living donor liver …

Recent deceased-donor allocation changes in the United States may have increased high-
Model for End-Stage Liver Disease (MELD) living donor liver transplantation (LDLT); …